Core Insights - Omada Health, Inc. reported a significant revenue increase of 58% in the fourth quarter and 53% for the full year 2025, reaching $76 million and $260 million respectively [1][7] - The company achieved positive net income of $5 million in the fourth quarter, a notable improvement from a net loss of $8 million in the same quarter of 2024, and narrowed its full-year net loss to $13 million from $47 million in 2024 [8][7] - Omada delivered positive adjusted EBITDA of $8 million in the fourth quarter and $6 million for the full year, compared to adjusted EBITDA losses in the previous year [14][8] Member Growth - Total membership reached 886,000 by year-end 2025, reflecting a 55% year-over-year growth [3] Revenue and Financial Performance - Revenue for the fourth quarter was $76 million, up 58% year-over-year, while the full-year revenue was $260 million, up 53% compared to 2024 [7] - Gross margin improved to 71% in the fourth quarter from 67% in Q4 2024, and for the full year, it was 66%, up from 61% in 2024 [8] - Non-GAAP gross margin for the fourth quarter was 73%, up from 69% in Q4 2024, and for the full year, it was 68%, compared to 63% in 2024 [8] Program Innovations and Offerings - The company introduced GLP-1 Flex Care, a new option for employers to connect eligible employees with clinical evaluation and ongoing medical oversight for GLP-1s, enhancing access and affordability [7][5] - Omada launched AI-powered tools, OmadaSpark and Meal Map, to support members with wellness education alongside human coaches [7][5] - In February 2026, Omada announced a new program, Omada for Cholesterol, to address prevalent conditions often co-existing with diabetes and obesity, expanding its cardiometabolic care capabilities [7][5] Financial Outlook - For the year ending December 31, 2026, Omada expects revenue in the range of $312 million to $322 million, representing a midpoint growth of 22% compared to 2025 [15] - Adjusted EBITDA is projected to be between $7 million and $15 million [15]
Omada Health Reports Fourth Quarter and Full-Year 2025 Results